18 results
PRE 14A
OMIC
Singular Genomics Systems Inc
5 Apr 24
Preliminary proxy
4:30pm
This Proxy Material and Voting
Directors, Executive Officers and Corporate Governance
Security Ownership of Certain Beneficial Owners and Management
Section 16 … AND CORPORATE GOVERNANCE
Executive Officers, Key Employees and Directors
Our executive officers, key employees and directors, and certain information
8-K
OMIC
Singular Genomics Systems Inc
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:29pm
and comply with Nasdaq’s corporate governance requirements.
As previously disclosed, on July 17, 2023, the Company received a letter from Nasdaq
S-3
EX-1.2
nleomo if6tg
19 Jul 22
Shelf registration
4:16pm
DEF 14A
t279vsf
14 Apr 22
Definitive proxy
5:00pm
10-K
xqew 171jwl4b
14 Mar 22
Annual report
4:06pm
8-K
EX-99.1
5risxlii3u8roa45sw
6 Jan 22
Singular Genomics Appoints Genomics Research Pioneer Elaine R. Mardis, Ph.D., to Board of Directors
4:15pm
8-K
EX-3.2
vn7gr7tr738czhz
1 Jun 21
Singular Genomics Systems, Inc. Announces Closing of
4:46pm
424B4
jss36t753tfft411
28 May 21
Prospectus supplement with pricing info
12:00am
S-1/A
6ugl9gbjf3r9obvdb
12 May 21
IPO registration (amended)
5:12pm
S-1
cqxi8rqtlle xdwu
7 May 21
IPO registration
4:18pm
DRS/A
b5zgdg9qpvztw wz1cle
26 Apr 21
Draft registration statement (amended)
12:00am
DRS
z7z r29cxk
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next